Imagen de Portada

Understanding the Increasing Prevalence of Obesity in Patients With Type 1 Diabetes: Strategies for Improving Clinical Care

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Kathleen R. Ruddiman, Jessica K. Bartfield, Irl B. Hirsch
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Obesity
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians
por: Pablo Aschner, et al.
Publicado: (2026)

Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity
por: Karan R. Chhabra, et al.
Publicado: (2026)

Prevalence of Clinical Obesity in US Adults, 2017–2020
por: Yun Shen, et al.
Publicado: (2025)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
por: Irl B. Hirsch, et al.
Publicado: (2024)

Redlining and Prevalent Obesity, Hypertension, and Diabetes in GuLF Study Participants
por: Marina R. Sweeney, et al.
Publicado: (2026)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
por: Faith Anne N. Heeren, et al.
Publicado: (2025)

Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
por: Mikhail Khachaturov, et al.
Publicado: (2026)

Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity
por: Anna Ferrulli, et al.
Publicado: (2025)

Obesity Prevalence Among U.S. Adults With and Without Disabilities
por: Cheryl D. Fryar, et al.
Publicado: (2026)

Bridging dose of U‐100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice‐daily glargine users
por: Arthi Thirumalai, et al.
Publicado: (2024)

Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
por: Satish K. Garg, et al.
Publicado: (2024)

Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
por: Kara D. Denstel, et al.
Publicado: (2026)

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
por: Hiba Jebeile, et al.
Publicado: (2025)

Clinical Outcomes in the Patient With Traumatic Brain Injury and Comorbid Obesity: A Scoping Review
por: Shawn R. Eagle, et al.
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2025)

Diabetes, Obesity and Metabolism
Publicado: (2026)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2026)

Diabetes, Obesity and Metabolism
Publicado: (2024)

Diabetes, Obesity and Metabolism
Publicado: (2026)

Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy
por: Jasmine Pipella, et al.
Publicado: (2026)

Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult Patients
por: V. Guarnotta, et al.
Publicado: (2026)

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
por: Renata Risi, et al.
Publicado: (2026)

Metabolic Outcomes in Patients With Type 2 Diabetes Prescribed Incretin‐Based Therapy and Referred or Not to a Weight Management Clinic: A Single‐Center Retrospective Analyses
por: Kathleen M. Robinson, et al.
Publicado: (2026)

Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
por: Hamlet Gasoyan, et al.
Publicado: (2025)

Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
por: Ru‐Tao Lin, et al.
Publicado: (2026)